GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Ending Cash Position

PharmaRoth Labs (PharmaRoth Labs) Ending Cash Position : $0.00 Mil (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Ending Cash Position?

PharmaRoth Labs's Ending Cash Position for the quarter that ended in Mar. 2011 was $0.00 Mil.


PharmaRoth Labs Ending Cash Position Historical Data

The historical data trend for PharmaRoth Labs's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Ending Cash Position Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Ending Cash Position
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaRoth Labs Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PharmaRoth Labs's Ending Cash Position for the fiscal year that ended in Jun. 2010 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0+0
=0.00

PharmaRoth Labs's Ending Cash Position for the quarter that ended in Mar. 2011 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00


PharmaRoth Labs Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines